Share-based Payment Arrangement, Expense of WEST PHARMACEUTICAL SERVICES INC from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
WEST PHARMACEUTICAL SERVICES INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • WEST PHARMACEUTICAL SERVICES INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $8,400,000, a 65% increase year-over-year.
  • WEST PHARMACEUTICAL SERVICES INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $21,400,000, a 35% increase year-over-year.
  • WEST PHARMACEUTICAL SERVICES INC annual Share-based Payment Arrangement, Expense for 2024 was $18,700,000, a 20% decline from 2023.
  • WEST PHARMACEUTICAL SERVICES INC annual Share-based Payment Arrangement, Expense for 2023 was $23,300,000, a 1.7% decline from 2022.
  • WEST PHARMACEUTICAL SERVICES INC annual Share-based Payment Arrangement, Expense for 2022 was $23,700,000, a 37% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

WEST PHARMACEUTICAL SERVICES INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $21,400,000 $8,400,000 +$3,300,000 +65% 01 Jul 2025 30 Sep 2025 10-Q 23 Oct 2025 2025 Q3
Q2 2025 $18,100,000 $7,400,000 +$3,100,000 +72% 01 Apr 2025 30 Jun 2025 10-Q 24 Jul 2025 2025 Q2
Q1 2025 $15,000,000 $1,300,000 -$3,700,000 -74% 01 Jan 2025 31 Mar 2025 10-Q 24 Apr 2025 2025 Q1
Q4 2024 $18,700,000 $4,300,000 +$2,900,000 +207% 01 Oct 2024 31 Dec 2024 10-K 18 Feb 2025 2024 FY
Q3 2024 $15,800,000 $5,100,000 -$800,000 -14% 01 Jul 2024 30 Sep 2024 10-Q 23 Oct 2025 2025 Q3
Q2 2024 $16,600,000 $4,300,000 -$3,200,000 -43% 01 Apr 2024 30 Jun 2024 10-Q 24 Jul 2025 2025 Q2
Q1 2024 $19,800,000 $5,000,000 -$3,500,000 -41% 01 Jan 2024 31 Mar 2024 10-Q 24 Apr 2025 2025 Q1
Q4 2023 $23,300,000 $1,400,000 -$5,300,000 -79% 01 Oct 2023 31 Dec 2023 10-K 18 Feb 2025 2024 FY
Q3 2023 $28,600,000 $5,900,000 -$100,000 -1.7% 01 Jul 2023 30 Sep 2023 10-Q 24 Oct 2024 2024 Q3
Q2 2023 $28,700,000 $7,500,000 +$2,000,000 +36% 01 Apr 2023 30 Jun 2023 10-Q 25 Jul 2024 2024 Q2
Q1 2023 $26,700,000 $8,500,000 +$3,000,000 +55% 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024 2024 Q1
Q4 2022 $23,700,000 $6,700,000 -$3,200,000 -32% 01 Oct 2022 31 Dec 2022 10-K 18 Feb 2025 2024 FY
Q3 2022 $26,900,000 $6,000,000 -$5,400,000 -47% 01 Jul 2022 30 Sep 2022 10-Q 26 Oct 2023 2023 Q3
Q2 2022 $32,300,000 $5,500,000 -$4,800,000 -47% 01 Apr 2022 30 Jun 2022 10-Q 27 Jul 2023 2023 Q2
Q1 2022 $37,100,000 $5,500,000 -$400,000 -6.8% 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023 2023 Q1
Q4 2021 $37,500,000 $9,900,000 +$3,600,000 +57% 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
Q3 2021 $33,900,000 $11,400,000 +$1,400,000 +14% 01 Jul 2021 30 Sep 2021 10-Q 27 Oct 2022 2022 Q3
Q2 2021 $32,500,000 $10,300,000 -$2,000,000 -16% 01 Apr 2021 30 Jun 2021 10-Q 28 Jul 2022 2022 Q2
Q1 2021 $34,500,000 $5,900,000 +$500,000 +9.3% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2022 Q1
Q4 2020 $34,000,000 $6,300,000 +$700,000 +12% 01 Oct 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
Q3 2020 $33,300,000 $10,000,000 +$4,600,000 +85% 01 Jul 2020 30 Sep 2020 10-Q 28 Oct 2021 2021 Q3
Q2 2020 $28,700,000 $12,300,000 +$5,100,000 +71% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 $23,600,000 $5,400,000 -$800,000 -13% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q4 2019 $24,400,000 $5,600,000 +$5,200,000 +1300% 01 Oct 2019 31 Dec 2019 10-K 22 Feb 2022 2021 FY
Q3 2019 $19,200,000 $5,400,000 +$100,000 +1.9% 01 Jul 2019 30 Sep 2019 10-Q 23 Oct 2020 2020 Q3
Q2 2019 $19,100,000 $7,200,000 +$1,200,000 +20% 01 Apr 2019 30 Jun 2019 10-Q 24 Jul 2020 2020 Q2
Q1 2019 $17,900,000 $6,200,000 +$2,800,000 +82% 01 Jan 2019 31 Mar 2019 10-Q 24 Apr 2020 2020 Q1
Q4 2018 $15,100,000 $400,000 -$2,100,000 -84% 01 Oct 2018 31 Dec 2018 10-K 23 Feb 2021 2020 FY
Q3 2018 $17,200,000 $5,300,000 +$700,000 +15% 01 Jul 2018 30 Sep 2018 10-Q 29 Oct 2019 2019 Q3
Q2 2018 $16,500,000 $6,000,000 +$500,000 +9.1% 01 Apr 2018 30 Jun 2018 10-Q 29 Jul 2019 2019 Q2
Q1 2018 $16,000,000 $3,400,000 -$100,000 -2.9% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q4 2017 $16,100,000 $2,500,000 -$2,900,000 -54% 01 Oct 2017 31 Dec 2017 10-K 24 Feb 2020 2019 FY
Q3 2017 $19,000,000 $4,600,000 $0 0% 01 Jul 2017 30 Sep 2017 10-Q 30 Oct 2018 2018 Q3
Q2 2017 $19,000,000 $5,500,000 +$600,000 +12% 01 Apr 2017 30 Jun 2017 10-Q 31 Jul 2018 2018 Q2
Q1 2017 $18,400,000 $3,500,000 -$1,100,000 -24% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q4 2016 $19,500,000 $5,400,000 +$10,600,000 01 Oct 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
Q3 2016 $8,900,000 $4,600,000 +$1,000,000 +28% 01 Jul 2016 30 Sep 2016 10-Q 31 Oct 2017 2017 Q3
Q2 2016 $7,900,000 $4,900,000 -$10,600,000 -68% 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2017 2017 Q2
Q1 2016 $18,500,000 $4,600,000 -$700,000 -13% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q4 2015 $19,200,000 $5,200,000 -$11,300,000 -185% 01 Oct 2015 31 Dec 2015 10-K 26 Feb 2018 2017 FY
Q3 2015 $30,500,000 $3,600,000 $0 0% 01 Jul 2015 30 Sep 2015 10-Q 31 Oct 2016 2016 Q3
Q2 2015 $30,500,000 $15,500,000 +$10,900,000 +237% 01 Apr 2015 30 Jun 2015 10-Q 01 Aug 2016 2016 Q2
Q1 2015 $19,600,000 $5,300,000 +$1,000,000 +23% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1
Q4 2014 $18,600,000 $6,100,000 +$500,000 +8.9% 01 Oct 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
Q3 2014 $18,100,000 $3,600,000 -$1,600,000 -31% 01 Jul 2014 30 Sep 2014 10-Q 02 Nov 2015 2015 Q3
Q2 2014 $19,700,000 $4,600,000 -$400,000 -8% 01 Apr 2014 30 Jun 2014 10-Q 03 Aug 2015 2015 Q2
Q1 2014 $20,100,000 $4,300,000 -$1,100,000 -20% 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015 2015 Q1
Q4 2013 $21,200,000 $5,600,000 +$2,000,000 +56% 01 Oct 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
Q3 2013 $19,200,000 $5,200,000 +$800,000 +18% 01 Jul 2013 30 Sep 2013 10-Q 03 Nov 2014 2014 Q3
Q2 2013 $18,400,000 $5,000,000 +$700,000 +16% 01 Apr 2013 30 Jun 2013 10-Q 01 Aug 2014 2014 Q2
Q1 2013 $17,700,000 $5,400,000 +$2,200,000 +69% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q4 2012 $15,500,000 $3,600,000 01 Oct 2012 31 Dec 2012 10-K 25 Feb 2015 2014 FY
Q3 2012 $4,400,000 01 Jul 2012 30 Sep 2012 10-Q 04 Nov 2013 2013 Q3
Q2 2012 $4,300,000 +$1,100,000 +34% 01 Apr 2012 30 Jun 2012 10-Q 05 Aug 2013 2013 Q2
Q1 2012 $3,200,000 -$100,000 -3% 01 Jan 2012 31 Mar 2012 10-Q 06 May 2013 2013 Q1
Q2 2011 $3,200,000 01 Apr 2011 30 Jun 2011 10-Q 06 Aug 2012 2012 Q2
Q1 2011 $3,300,000 01 Jan 2011 31 Mar 2011 10-Q 04 May 2012 2012 Q1

WEST PHARMACEUTICAL SERVICES INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $18,700,000 -$4,600,000 -20% 01 Jan 2024 31 Dec 2024 10-K 18 Feb 2025 2024 FY
2023 $23,300,000 -$400,000 -1.7% 01 Jan 2023 31 Dec 2023 10-K 18 Feb 2025 2024 FY
2022 $23,700,000 -$13,800,000 -37% 01 Jan 2022 31 Dec 2022 10-K 18 Feb 2025 2024 FY
2021 $37,500,000 +$3,500,000 +10% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
2020 $34,000,000 +$9,600,000 +39% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
2019 $24,400,000 +$9,300,000 +62% 01 Jan 2019 31 Dec 2019 10-K 22 Feb 2022 2021 FY
2018 $15,100,000 -$1,000,000 -6.2% 01 Jan 2018 31 Dec 2018 10-K 23 Feb 2021 2020 FY
2017 $16,100,000 -$3,400,000 -17% 01 Jan 2017 31 Dec 2017 10-K 24 Feb 2020 2019 FY
2016 $19,500,000 +$300,000 +1.6% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $19,200,000 +$600,000 +3.2% 01 Jan 2015 31 Dec 2015 10-K 26 Feb 2018 2017 FY
2014 $18,600,000 -$2,600,000 -12% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $21,200,000 +$5,700,000 +37% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
2012 $15,500,000 +$7,100,000 +85% 01 Jan 2012 31 Dec 2012 10-K 25 Feb 2015 2014 FY
2011 $8,400,000 +$600,000 +7.7% 01 Jan 2011 31 Dec 2011 10-K 27 Feb 2014 2013 FY
2010 $7,800,000 01 Jan 2010 31 Dec 2010 10-K 27 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.